World's Best Scientists 2026 revealed!
Award Badge
Genetics
UK
2024
Award Badge
Genetics and Molecular Biology
UK
2024

D-Index & Metrics

Genetics

D-Index
137
Citations
81518
World Ranking
206
National Ranking
39

Medicine

D-Index
138
Citations
83416
World Ranking
1811
National Ranking
188

Bruce A.J. Ponder publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Bruce A.J. Ponder sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 437 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Bruce A.J. Ponder D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Bruce A.J. Ponder sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 137 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 2024 - Research.com Genetics in United Kingdom Leader Award
  • 2024 - Research.com Genetics and Molecular Biology in United Kingdom Leader Award
  • 2023 - Research.com Genetics in United Kingdom Leader Award
  • 2001 - Fellow of the Royal Society, United Kingdom

Overview

Bruce A.J. Ponder is affiliated with the University of Cambridge in the United Kingdom. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with additional contributions in Medicine. Their work covers several subfields including Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics, and Oncology.

The scientist's main topics of research include:

  • Cancer-related molecular mechanisms research
  • Ferroptosis and cancer prognosis
  • Genomics and Chromatin Dynamics
  • Genetic Associations and Epidemiology
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Bioinformatics and Genomic Networks

Among their recent papers are the following:

  • "Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk," published in 2024 in Genome Medicine
  • "Identification of candidate causal variants and target genes at 41 breast cancer risk loci through differential allelic expression analysis," published in 2024 in Scientific Reports
  • "Mapping of cis-regulatory variants by differential allelic expression analysis identifies candidate causal variants and target genes of 41 breast cancer risk loci," published in 2022 in bioRxiv (Cold Spring Harbor Laboratory)
  • "Multi-cohort analysis identifies a blood-based immune transcriptomic signature for early lung cancer detection," published in 2025 in npj Precision Oncology

The frequent co-authors collaborating with Bruce A.J. Ponder include:

  • Martin O'Reilly
  • Robert C. Rintoul
  • Joana M. Xavier
  • Ramiro Magno
  • Roslin Russell

Most of their publications appear in journals such as Genome Medicine, Scientific Reports, bioRxiv (Cold Spring Harbor Laboratory), and npj Precision Oncology.

Bruce A.J. Ponder was awarded the Fellowship of the Royal Society, United Kingdom, in 2001.

Best Publications

  • Identification of the breast cancer susceptibility gene BRCA2

    Wooster R;Bignell G;Lancaster J;Swift S

  • Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

    D Ford;D F Easton;M Stratton;S Narod

  • Genome-wide association study identifies novel breast cancer susceptibility loci

    Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah

  • Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13

    Richard Wooster;Susan L. Neuhausen;Jonathan Mangion;Yvette Quirk

  • CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

    Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian

  • Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

    L M Mulligan;J B Kwok;C S Healey;M J Elsdon

  • Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer

    H. Telenius;N. P. Carter;C. E. Bebb;M. Nordenskjold

  • The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

    Charis Eng;Charis Eng;David Clayton;Isabelle Schuffenecker;Gilbert Lenoir

  • Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

    Zhou Songyang;Zhou Songyang;Kermit L. Carraway;Michael J. Eck;Stephen C. Harrison

  • GDNF signalling through the Ret receptor tyrosine kinase

    Pascale Durbec;Camelia V. Marcos-Gutierrez;Carol Kilkenny;Maria Grigoriou

  • Mutations of the RET proto-oncogene in Hirschsprung's disease

    Patrick Edery;Stanislas Lyonnet;Lois M. Mulligan;Anna Pelet

  • Polygenic susceptibility to breast cancer and implications for prevention

    Paul D.P. Pharoah;Antonis Antoniou;Martin Bobrow;Ron L. Zimmern

  • Family history and the risk of breast cancer: A systematic review and meta‐analysis

    Paul D.P. Pharoah;Nicholas E. Day;Stephen Duffy;Douglas F. Easton

  • Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

    S. A. Narod;H. Risch;R. Moslehi;A. Dorum

  • Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations

    Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson

  • Involvement of Brca2 in DNA repair.

    Ketan J Patel;Veronica P.C.C Yu;Hyunsook Lee;Anne Corcoran

  • The genetics and genomics of cancer

    Allan Balmain;Joe Gray;Bruce Ponder

  • Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

    Lois M. Mulligan;Lois M. Mulligan;Charis Eng;Catherine S. Healey;David Clayton

  • Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

    B. R. Seizinger;G. A. Rouleau;L. J. Ozelius;A. H. Lane

  • Erratum: Identification of the breast cancer susceptibility gene BRCA2

    Richard Wooster;Graham Bignell;Jonathan Lancaster;Sally Swift

Frequent Co-Authors

Douglas F. Easton
Douglas F. Easton University of Cambridge
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge
Alison M. Dunning
Alison M. Dunning University of Cambridge
Lois M. Mulligan
Lois M. Mulligan Queen's University
Charis Eng
Charis Eng Cleveland Clinic Lerner College of Medicine
Catherine S. Healey
Catherine S. Healey University of Cambridge
Susan J. Ramus
Susan J. Ramus University of New South Wales
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Alice S. Whittemore
Alice S. Whittemore Stanford University
Robert Luben
Robert Luben University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Genetics, a wide range of related online degrees and career options are available. Many are in health sciences, where genetics plays a critical role. A popular pathway is nursing, where applicants often wonder, is the teas test required for all nursing programs. Knowing the admissions requirements can help you choose the right program to begin your healthcare journey.

If administration interests you, consider exploring the cheapest online mha programs. These programs provide cost-effective ways to advance into leadership roles within healthcare. Alternatively, those wanting a practical, fast entry into nursing can look into an lpn accelerated program, delivering hands-on experience and quick job access.

For advanced research careers, online options are expanding. Aspirants can now find phd nursing programs online that support flexibility for working professionals and foster the skills needed for both clinical and academic roles. Whether choosing clinical practice, leadership, or research, these online pathways allow genetics students to diversify their career options and make a real impact in healthcare.

Best Scientists Citing Bruce A.J. Ponder

Trending Scientists

Recently Published Articles